Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Bile Acid Metabolism-Based Integrative Subtyping Reveals CLCA1, UGT2A3, and ZG16 as Indicators of Immune Dysfunction and Adverse Outcomes in Colorectal Cancer

  • By

  • Li Feng

  • Min Wang

  • Xin Li

  • Long Wu

  • DeXin Gu

  • Bin Zhang

  • Peng Zheng

  • Qifeng Yang

  • Ke Wang

  • Gang Mao

  • August 27, 2026

Share

  • 1

    The article discusses a correction regarding integrative subtyping by bile acid metabolism in colorectal cancer.

  • 2

    CLCA1, UGT2A3, and ZG16 are identified as markers of immune dysfunction and poor prognosis in colorectal cancer.

  • 3

    The correction addresses an inaccurate funding statement in the original publication.

  • 4

    The accurate funding statement credits the Sichuan Science and Technology Program for financial support.

  • 5

    The original version of the article has been updated to reflect these corrections.

Original Source(s)

Correction: Integrative subtyping by bile acid metabolism identifies CLCA1/UGT2A3/ZG16 as markers of immune dysfunction and poor prognosis in colorectal cancer

  • by Li Feng, Min Wang, Xin Li, Long Wu, DeXin Gu, Bin Zhang, Peng Zheng, Qifeng Yang, Ke Wang, Gang Mao

  • August 27, 2026

Related Content

Letter to the editor regarding “Impact of gross tumor morphology on the clinical outcomes of colon cancer: multicenter retrospective cohort study”

Association between preoperative neutrophil percentage-to-albumin ratio and survival outcomes in patients with colorectal cancer undergoing radical surgery: a retrospective study with external validation

Correction: Plasticity and antigen presentation by group 3 innate lymphoid cells in colorectal cancer